Skip to main content
21 search results for:

EASD 2022 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 09-23-2022 | EASD 2022 | News | Article

    ADA/EASD hyperglycemia management consensus update strengthens holistic care

    The latest update to the ADA and EASD hyperglycemia management consensus report places a strong emphasis on holistic, person-centered care for type 2 diabetes.

  2. 09-23-2022 | EASD 2022 | News | Article

    Topical esmolol hydrochloride may aid healing of diabetic foot ulcers

    The use of esmolol hydrochloride in adults with diabetic foot ulcer improves wound healing and may constitute a novel treatment option, suggests research reported at the 58th EASD Annual Meeting in Stockholm, Sweden.

  3. 09-22-2022 | EASD 2022 | News | Article

    Model could predict severe hypoglycemia risk in people with type 2 diabetes

    A number of factors are associated with severe hypoglycemia risk in people with type 2 diabetes treated with insulin or sulfonylureas, suggests research reported at the 58th EASD Annual Meeting in Stockholm, Sweden.

  4. 09-23-2022 | EASD 2022 | News | Article

    ​​​​​​​Better diabetes self-care during adolescence could improve glycemic control trajectory

    Based on these findings, Marks concluded that healthcare providers should always involve the caregivers when discussing diabetes self-care. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  5. 09-23-2022 | EASD 2022 | News | Article

    ​​​​​​​ReTUNE analysis backs ‘personal fat threshold’ concept

    But the presenter stressed the importance of thorough screening for type 1 diabetes and MODY in this relatively lean population. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  6. 09-23-2022 | EASD 2022 | News | Article

    Bolus timing requires more attention in people using advanced technologies for type 1 diabetes

    Therefore, “we should have structured educational programs” to improve mealtime bolus timing, concluded Annuzzi. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  7. 09-23-2022 | EASD 2022 | News | Article

    Degree of autoimmunity impacts CVD risk in LADA

    Wei concluded that people with LADA could be stratified into two disease trajectory groups based on GADA levels, in order to “help with more efficient and individualized LADA management.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  8. 09-23-2022 | EASD 2022 | News | Article

    Childhood body size modifies diabetes risk in adulthood

    In response to an audience question, Carrasquilla suggested that physicians could consider childhood body size when assessing diabetes risk, although he advised basing this on objective measurements taken in childhood rather than self-report where possible. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  9. 09-22-2022 | EASD 2022 | News | Article

    High-intensity exercise may be beneficial for people with impaired hypoglycemia awareness

    She noted that the mechanisms underlying benefits of high-intensity exercise for restoring hypoglycemia awareness are unknown, but suggested that they could involve reaction of the autonomic nervous system, heightened sensitivity of adrenergic receptors, or increased central nervous system glucagon release. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  10. 09-22-2022 | EASD 2022 | News | Article

    Microalbuminuria in pregnancy forecasts adverse outcomes

    Asatiani stressed, however, that the occurrences of kidney transplant and death were around 10 years ago, noting that in more recent years they have had good results treating similar patients with newer medications such as dapagliflozin. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  11. 09-22-2022 | EASD 2022 | News | Article

    Support for tailored genetic counseling in people with incidentally discovered MODY mutations

    Together, these findings indicate that “we cannot use family-based risk information to counsel the people who are incidentally found to have HNF1A and HNF4A mutations, but we can use that for glucokinase MODY,” concluded the presenter. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  12. 09-22-2022 | EASD 2022 | News | Article

    ​​​​​​​Psychologic resilience tied to glycemic control after type 1 diabetes diagnosis

    Each 10-point increase in resilience was associated with 1.1 mmol/mol lower HbA1c during follow-up, which was not statistically significant ( p =0.06). medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  13. 09-21-2022 | EASD 2022 | News | Article

    Skin reactions rarely lead to diabetes device discontinuation

    Just 3% consulted a dermatologist. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  14. 09-21-2022 | EASD 2022 | News | Article

    isCGM benefits sustained for at least 2 years

    But he said the comparison used is “the best that we have” in terms of a real-world study. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  15. 09-21-2022 | EASD 2022 | News | Article

    C-peptide may be better than CRP for predicting cardiovascular risk in type 2 diabetes

    Therefore, “C-peptide is a better marker of future risk of cardiovascular disease, whereas CRP is a better marker of increased risk of all-cause mortality,” summarized the presenter “This emphasizes the need to treat insulin resistance in prevention of cardiovascular events,” she concluded. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  16. 09-21-2022 | EASD 2022 | News | Article

    Libre upgrade illustrates power of hypoglycemia alerts

    “I think this is potentially an important area for us to intervene on,” said Gibb, suggesting that people with a high time below range should be encouraged “to set their sensor threshold higher to get the maximum benefit from this system.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  17. 09-20-2022 | EASD 2022 | News | Article

    ​​​​​​​Fully closed-loop control boosts TIR in insulin-treated type 2 diabetes

    Concluding, Boughton highlighted the small size of the study and the almost completely White population, and stressed the need for larger studies to ensure generalizability and determine cost-effectiveness. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Sept 19–23, 2022

  18. 09-20-2022 | EASD 2022 | News | Article

    Freestyle Libre cuts acute complication risk in insulin-treated type 2 diabetes

    “This suggests that Freestyle Libre should be more widely prescribed as part of individualized care for patients with type 2 diabetes treated with a basal-only insulin regimen,” Riveline concluded. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  19. 09-20-2022 | EASD 2022 | News | Article

    Fatty liver index may predict mortality, CVD risk in people with type 1 diabetes

    Together, these findings indicate that hepatic steatosis “is an independent predictor of all-cause mortality and incidence of major CV and coronary events” in the type 1 diabetes population, concluded Penno. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

  20. 09-20-2022 | EASD 2022 | News | Article

    Insulin pump delivery may reduce fatty liver risk in type 1 diabetes

    “It is likely that female gender offers the optimal hormonal milieu to exploit the beneficial effects of lower peripheral insulin on visceral adipose tissue distribution,” Bozzetto concluded. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group EASD Annual Meeting; Stockholm, Sweden: Sept 19–23, 2022

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.